Ildong Pharmaceutical Co., Ltd. (KRX:249420)
South Korea · Delayed Price · Currency is KRW 21,750
-1,450 (-6.25%)
At close: Jul 21, 2025, 3:30 PM KST
Ildong Pharmaceutical Revenue
Ildong Pharmaceutical had revenue of 135.98B KRW in the quarter ending March 31, 2025, a decrease of -10.01%. This brings the company's revenue in the last twelve months to 599.82B, down -0.99% year-over-year. In the year 2024, Ildong Pharmaceutical had annual revenue of 614.94B with 2.36% growth.
Revenue (ttm)
599.82B
Revenue Growth
-0.99%
P/S Ratio
1.01
Revenue / Employee
580.66M
Employees
1,033
Market Cap
607.53B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,898.69B |
| Celltrion | 3,662.23B |
| ALTEOGEN | 151.65B |
| Yuhan | 2,114.76B |
| SK Biopharmaceuticals | 578.00B |
| HLB Co., Ltd. | 74.64B |
| Peptron | 4.30B |
| PharmaResearch | 392.31B |